Scleral Lens and Prosthetic Replacement of the Ocular Surface Ecosystem Utilization in Ocular Graft-versus-Host Disease: A Survey Study

被引:10
|
作者
Bligdon, Shannon M. [1 ]
Colarusso, Bradley A. [2 ]
Ganjei, Allen Y. [3 ]
Kwok, Alan [4 ]
Luo, Zhonghui Katie [2 ]
Brocks, Daniel [4 ]
机构
[1] Ajax Eye Care, Ajax, ON, Canada
[2] Massachusetts Eye & Ear, Boston, MA USA
[3] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA
[4] BostonSight, 464 Hillside Ave,Unit 205, Needham, MA 02494 USA
来源
CLINICAL OPHTHALMOLOGY | 2021年 / 15卷
关键词
GVHD; oGVHD; dry eye; keratoconjunctivitis sicca; QOL; HSCT; allo-HSCT; QUALITY-OF-LIFE; DRY EYE; PROSE TREATMENT; RISK-FACTORS; MANAGEMENT; DIAGNOSIS; SYMPTOMS; THERAPY; SIGNS;
D O I
10.2147/OPTH.S337824
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To evaluate the utilization of scleral lenses and prosthetic replacement of the ocular surface ecosystem devices (SL/PDs) in the management of ocular graft-versus-host disease (oGVHD). Patients and Methods: A survey of 15 questions was sent via email to 6032 subjects registered with the Blood and Marrow Transplant Information Network. The survey reviewed transplant history, graft-versus-host disease history, as well as oGVHD symptoms and onset. Additional questions surveyed treatments used for oGVHD, as well as the degree of ocular symptom control and experience with SL/PDs. A total of 306 respondents met the eligibility requirements to be part of the analyzed cohort. Results: The mean number of symptoms reported from the analyzed cohort was 4.79 +/- 2.44, median (IQR) of 5.0 (3.0 to 7.0), with the most common symptom being gritty, dry eyes (87%). The mean number of treatments utilized across the analyzed cohort was 3.21 +/- 2.55, median (IQR) of 2.5 (1.0 to 5.0), with the most common treatment being artificial tears (86%). Wearing scleral lenses resulted in a mean of 5.42 +/- 1.86, median (IQR) of 6.0 (4.0 to 7.0) symptoms improving, with improved dryness/grittiness of the eyes (94%), improved eye pain (92%) and improved quality of life (89%) being the most commonly improved symptoms. Fifty-six percent of those wearing scleral lenses wished the lenses had been recommended sooner. The most common reason patients cited for not wearing scleral lenses was that they had never heard of them (63%). Conclusion: SL/PDs help to control the symptoms of oGVHD. With their use, clinicians are able to improve the quality of life of this patient population. Despite the known benefits, SL/PDs still remain underutilized in oGVHD care. A majority of current SL/PD wearers wish that they had been recommended sooner as a treatment option. SL/PDs should be considered a component of comprehensive oGVHD management.
引用
收藏
页码:4829 / 4838
页数:10
相关论文
共 50 条
  • [1] Use of Prosthetic Replacement of the Ocular Surface Ecosystem Scleral Lenses in Patients with Ocular Chronic Graft-versus-Host Disease
    Theophanous, Christos
    Irvine, John A.
    Parker, Pablo
    Chiu, Gloria B.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (12) : 2180 - 2184
  • [2] Treatment of severe ocular surface disease from ocular chronic graft-versus-host disease with a scleral len prosthetic device
    Jacobs, D. S.
    Rosenthal, P.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 109 - 110
  • [3] Improvements in visual acuity and function with Prosthetic Replacement of the Ocular Surface Ecosystem scleral lens in patients with ocular surface disease
    Mannis, Tova
    Bach, Dianne
    Chiu, Gloria
    Bababeygy, Simon
    Irvine, John
    Heur, J. Martin
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [4] Prosthetic Replacement of the Ocular Surface Ecosystem Scleral Lens Therapy for Exposure Keratopathy
    Chahal, Jasdeep S.
    Heur, Martin
    Chiu, Gloria B.
    EYE & CONTACT LENS-SCIENCE AND CLINICAL PRACTICE, 2017, 43 (04): : 240 - 244
  • [5] Assessment of the Prosthetic Replacement of Ocular Surface Ecosystem (PROSE) scleral lens on visual acuity for corneal irregularity and ocular surface disease
    Parra, Andres S.
    Roth, Bryan M.
    Nguyen, Taylor M.
    Wang, Li
    Pflugfelder, Stephen C.
    Al-Mohtaseb, Zaina
    OCULAR SURFACE, 2018, 16 (02): : 254 - 258
  • [6] Ocular Graft-versus-Host Disease Underdiagnosis: A Survey Study
    Colarusso, Bradley A.
    Bligdon, Shannon M.
    Ganjei, Allen Y.
    Kwok, Alan
    Brocks, Daniel
    Luo, Zhonghui K.
    CLINICAL OPHTHALMOLOGY, 2022, 16 : 1419 - 1426
  • [7] Ocular graft-versus-host disease
    Dietrich-Ntoukas, T.
    Steven, P.
    OPHTHALMOLOGE, 2015, 112 (12): : 1027 - 1038
  • [8] Ocular graft-versus-host disease
    Hessen, Michelle
    Akpek, Esen K.
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 12 (05) : 540 - 547
  • [9] Ocular Surface Disease Characteristics in Patients with Ocular Graft-versus-Host Disease (GVHD).
    Shikari, Hasanain
    Saboo, Ujwala
    Dana, Reza
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [10] Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE) scleral lens for Salzmann's nodular degeneration
    Chiu, Gloria B.
    Bach, Dianne
    Theophanous, Christos
    Heur, Martin
    SAUDI JOURNAL OF OPHTHALMOLOGY, 2014, 28 (03) : 203 - 206